Advertisement

Topics

PubMed Journals Articles About "Therapure Biopharma Inc." RSS

14:03 EDT 22nd May 2018 | BioPortfolio

Therapure Biopharma Inc. PubMed articles on BioPortfolio. Our PubMed references draw on over 21 million records from the medical literature. Here you can see the latest Therapure Biopharma Inc. articles that have been published worldwide.

More Information about "Therapure Biopharma Inc." on BioPortfolio

We have published hundreds of Therapure Biopharma Inc. news stories on BioPortfolio along with dozens of Therapure Biopharma Inc. Clinical Trials and PubMed Articles about Therapure Biopharma Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Therapure Biopharma Inc. Companies in our database. You can also find out about relevant Therapure Biopharma Inc. Drugs and Medications on this site too.

Showing "Therapure Biopharma" PubMed Articles, all 2

Rethinking the Clinically Based Thresholds of TransCelerate BioPharma for Risk-Based Monitoring.

The quality of data from clinical trials has received a great deal of attention in recent years. Of central importance is the need to protect the well-being of study participants and maintain the integrity of final analysis results. However, traditional approaches to assess data quality have come under increased scrutiny as providing little benefit for the substantial cost. Numerous regulatory guidance documents and industry position papers have described risk-based approaches to identify quality and safety...


The positive impacts of Real-World Data on the challenges facing the evolution of biopharma.

Demand for healthcare services is unprecedented. Society is struggling to afford the cost. Pricing of biopharmaceutical products is under scrutiny, especially by payers and Health Technology Assessment agencies. As we discuss here, rapidly advancing technologies, such Real-World Data (RWD), are being utilized to increase understanding of disease. RWD, when captured and analyzed, produces the Real-World Evidence (RWE) that underpins the economic case for innovative medicines. Furthermore, RWD can inform the ...


Advertisement
Quick Search
Advertisement
Advertisement